Biologists at University of Massachusetts Medical School (UMMS) have developed a new monoclonal antibody therapy that has managed to prevent hepatitis C infection in an animal model. Researchers found that the human monoclonal antibody targeting the virus protected chimpanzees from HCV infection in a dose-dependent manner in a study conducted at Texas Biomed's Southwest National Primate Research Center in San Antonio. Chimpanzees are the only species ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment